BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11553362)

  • 1. Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.
    Mishima K; Tsukikawa H; Inada K; Fujii M; Iwasaki K; Matsumoto Y; Abe K; Egawa T; Fujiwara M
    Eur J Pharmacol; 2001 Sep; 427(1):43-52. PubMed ID: 11553362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
    Mishima K; Tsukikawa H; Miura I; Inada K; Abe K; Matsumoto Y; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2003 Mar; 44(4):541-52. PubMed ID: 12646291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats.
    Mishima K; Iwasaki K; Tsukikawa H; Matsumoto Y; Egashira N; Abe K; Egawa T; Fujiwara M
    Jpn J Pharmacol; 2000 Oct; 84(2):163-73. PubMed ID: 11128039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats.
    Fujiwara M; Ohgami Y; Inada K; Iwasaki K
    Behav Brain Res; 1997 Feb; 83(1-2):91-6. PubMed ID: 9062666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats.
    Taga C; Sugimoto Y; Nishiga M; Fujii Y; Kamei C
    Eur J Pharmacol; 2001 Jul; 423(2-3):167-70. PubMed ID: 11448481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat.
    Ogren SO; Kehr J; Schött PA
    Neuroscience; 1996 Dec; 75(4):1127-40. PubMed ID: 8938746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arginine-vasopressin fragment 4-9 on rodent cholinergic systems.
    Tanabe S; Shishido Y; Nakayama Y; Furushiro M; Hashimoto S; Terasaki T; Tsujimoto G; Yokokura T
    Pharmacol Biochem Behav; 1999 Aug; 63(4):549-53. PubMed ID: 10462183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a novel AVP(4-9) binding site in rat hippocampus.
    Nakayama Y; Takano Y; Shimohigashi Y; Tanabe S; Fujita T; Kamiya H; Tsujimoto G
    Brain Res; 2000 Mar; 858(2):416-23. PubMed ID: 10708695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation in rats of impairments of memory by scopolamine, a muscarinic receptor antagonist, by mecamylamine, a nicotinic receptor antagonist.
    Newman LA; Gold PE
    Psychopharmacology (Berl); 2016 Mar; 233(5):925-32. PubMed ID: 26660295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of the cholinergic system in ameliorating effect of vasopressin fragment by group I metabotropic glutamate-receptor blockade.
    Tarumi T; Mikami A; Shimada K; Kamei C
    J Pharmacol Sci; 2008 Nov; 108(3):335-40. PubMed ID: 19008649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular pathways of V(1) and V(2) receptors activated by arginine vasopressin in rat hippocampal neurons.
    Omura T; Nabekura J; Akaike N
    J Biol Chem; 1999 Nov; 274(46):32762-70. PubMed ID: 10551836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorative effects of histamine on spatial memory deficits induced by scopolamine infusion into bilateral dorsal or ventral hippocampus as evaluated by the radial arm maze task.
    Xu LS; Fan YY; He P; Zhang WP; Hu WW; Chen Z
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):816-21. PubMed ID: 19215234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
    Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M
    Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
    Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
    Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of hippocampal postsynaptic muscarinic receptors is involved in long-term spatial memory formation.
    Herrera-Morales W; Mar I; Serrano B; Bermúdez-Rattoni F
    Eur J Neurosci; 2007 Mar; 25(5):1581-8. PubMed ID: 17355252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial septal galanin and acetylcholine: influence on hippocampal acetylcholine and spatial learning.
    Elvander E; Ogren SO
    Neuropeptides; 2005 Jun; 39(3):245-8. PubMed ID: 15944017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice.
    Wall PM; Flinn J; Messier C
    Psychopharmacology (Berl); 2001 Apr; 155(1):58-68. PubMed ID: 11374337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NNZ-2591, a novel diketopiperazine, prevented scopolamine-induced acute memory impairment in the adult rat.
    Guan J; Zhang R; Dale-Gandar L; Hodgkinson S; Vickers MH
    Behav Brain Res; 2010 Jul; 210(2):221-8. PubMed ID: 20188767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition.
    Elvander E; Schött PA; Sandin J; Bjelke B; Kehr J; Yoshitake T; Ogren SO
    Neuroscience; 2004; 126(3):541-57. PubMed ID: 15183504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.